[1]
“Patient-Derived Organoids as a Predictive Assay: Concordance With Clinical Response in Colorectal Cancer”, TMTJ, vol. 1, no. 1, pp. 19–27, Mar. 2022, doi: 10.5281/zenodo.22648824.